S8875
碳酸氢钠
ReagentPlus®, ≥99.5%, powder
别名:
碳酸氢钠，EMPROVE® ESSENTIAL，符合Ph Eur、BP、JP、USP、FCC、E 500标准, 小苏打
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
线性分子式:
NaHCO3
化学文摘社编号:
分子量:
84.01
UNSPSC Code:
12352302
NACRES:
NA.21
PubChem Substance ID:
EC Number:
205-633-8
Beilstein/REAXYS Number:
4153970
MDL number:
eCl@ss:
38020213
Assay:
≥99.5%
Form:
powder
agency
suitable for EPA 300
Quality Level
product line
ReagentPlus®
assay
≥99.5%
form
powder
pKa (25 °C)
(1) 6.37, (2) 10.25 (carbonic acid)
density
2.16 g/mL at 25 °C (lit.)
SMILES string
[Na+].OC([O-])=O
InChI
1S/CH2O3.Na/c2-1(3)4;/h(H2,2,3,4);/q;+1/p-1
InChI key
UIIMBOGNXHQVGW-UHFFFAOYSA-M
General description
碳酸氢钠通常被称为小苏打。它作为二氧化碳的来源，并用于制备各种钠盐。它也是一种重要的 ph 调节剂。
Application
碳酸氢钠可用作催化剂：
- 在硫酸钠作助催化剂的情况下，由相应的醛和盐酸羟胺合成腈。
- 用取代 2-甲酰苯基 2-溴乙酸酯分子内维蒂希反应制备香豆素衍生物。
- 通过与乙酸酐反应，用于伯醇和酚的乙酰化过程。
Legal Information
ReagentPlus is a registered trademark of Merck KGaA, Darmstadt, Germany
Still not finding the right product?
Explore all of our products under 碳酸氢钠
存储类别
11 - Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
实验方案
This procedure may be used for the determination of Amyloglucosidase activity using starch as the substrate.
This procedure may be used for all Ficin products.
本操作程序可用于使用淀粉作为底物测定淀粉葡萄糖苷酶的活性。
相关内容
This page is intended to make it easier to find the consumables you need based on the analytical method you’re using. Methods included on this page come from the EPA, Standard Methods and ASTM.
Somjot S Brar et al.
Clinical journal of the American Society of Nephrology : CJASN, 4(10), 1584-1592 (2009-08-29)
Infusion of sodium bicarbonate has been suggested as a preventative strategy but reports are conflicting on its efficacy. The aim of this study was to assess the effectiveness of hydration with sodium bicarbonate for the prevention of contrast-induced acute kidney
Sophia Zoungas et al.
Annals of internal medicine, 151(9), 631-638 (2009-11-04)
Intravenous sodium bicarbonate has been proposed to reduce the risk for contrast-induced nephropathy (CIN). To determine the effect of sodium bicarbonate on the risk for CIN. MEDLINE, PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials from 1950 to
Eric A J Hoste et al.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 25(3), 747-758 (2009-08-26)
There have been conflicting reports on the use of intravenous administration of sodium bicarbonate for prevention of contrast-induced acute kidney injury (CI-AKI). The aim of this study was to evaluate the use of sodium bicarbonate for prevention of CI-AKI. This
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| S8875-25KG | 04061833445075 |
| S8875-2.5KG | 04061835279432 |
| S8875-5KG | 04061835279456 |
| S8875-1KG | 04061835279418 |
| S8875-500G | 04061835279449 |